Astria Therapeutics
ATXS
ATXS
65 hedge funds and large institutions have $312M invested in Astria Therapeutics in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 11 reducing their positions, and 11 closing their positions.
Holders
65
Holders Change
+4
Holders Change %
+6.56%
% of All Funds
1.04%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
15
Increased
28
Reduced
11
Closed
11
Calls
$316K
Puts
$118K
Net Calls
+$198K
Net Calls Change
-$2.79M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$17.5M |
2 |
2
Balyasny Asset Management
Chicago,
Illinois
|
$6.46M |
3 |
3
BlackRock
New York
|
$3.84M |
4 |
IC
4
Ikarian Capital
Dallas,
Texas
|
$11.6M |
5 |
LGM
5
Logos Global Management
San Francisco,
California
|
$13.9M |